Upgrade to SI Premium - Free Trial

Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy

September 1, 2026 7:36 AM
(Updated - September 1, 2026 7:36 AM EDT)

Chardan analyst Keay Nakae assumes coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot New Coverage New Coverage